Keyword: Nexavar

Markets & Companies

The Future Lies in the Genome

07.10.2015 - Kemal Malik, board member for innovation at the German Bayer Group, sees many similarities in the genetic system of humans, animals and plants. This opens the door for synergies in...

News

Avella to Distribute Bayer’s Nexavar and Stivarga in US

23.02.2015 - Bayer has named Avella Specialty Pharmacy as one of the limited group of specialty pharmacies authorized to distribute two of its oral oncology drugs, Nexavar (sorafenib) and...

News

Bayer Fails to Block Cancer Generic in India

16.12.2014 - Bayer has failed in the last round of its effort to block the sale of a cheap generic version of its cancer drug Nexavar in India. In a Dec. 12 decision, the country's Supreme...

News

Amgen Buys Onyx for $10.4 Billion

26.08.2013 - Amgen struck a deal to buy cancer drug maker Onyx Pharmaceuticals for about $10.4 billion on Sunday, as it moves to restock its product pipeline in response to declining sales of...

News

Amgen deal for Onyx possible Within Week

09.08.2013 - Onyx Pharmaceuticals is close to selling itself to larger rival Amgen as the cancer drug maker's high stock price has discouraged other companies from making a counteroffer so far...

News

Pfizer, Novartis May Join Amgen in Bidding for Onyx

02.07.2013 - Onyx Pharmaceuticals, whose cancer drugs promise a strong revenue stream, is attracting preliminary buyout interest from several large pharmaceutical companies such as Pfizer and...

News

Onyx Rejects Amgen Offer, Explores Possible Sale

01.07.2013 - Cancer drugmaker Onyx Pharmaceuticals said on Sunday it rejected a roughly $10 billion takeover offer from larger biotechnology company Amgen as too low but still is considering...

News

India to Give Free Generic Drugs to Hundreds of Millions

05.07.2012 - India has put in place a $5.4 billion policy to provide free medicine to its people, a decision that could change the lives of hundreds of millions, but a ban on branded drugs...